Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $80.32 USD
Change Today +0.26 / 0.32%
Volume 176.0K
HELE On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

helen of troy ltd (HELE) Key Developments

Helen of Troy Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended November 30, 2014; Revises Earnings Guidance for the Fiscal Year 2015

Helen of Troy Limited reported unaudited consolidated earnings results for the third quarter and nine months ended November 30, 2014. For the quarter, the company reported sales revenue of $435.674 million compared to $380.730 million a year ago. Income before income taxes were $60.957 million compared to $46.893 million a year ago. Net income was $55.377 million compared to $37.524 million a year ago. Diluted EPS was $1.92 compared to $1.16 a year ago. EBITDA was $75.698 million compared to $58.109 million a year ago. Adjusted EBITDA was $77.025 million compared to $60.512 million a year ago. Foreign currency exchange rate fluctuations decreased reported net sales revenue by $2.8 million year-over-year. Operating income was $65.0 million compared to operating income of $49.4 million in the same period last year. On an adjusted basis for the third quarter of fiscal years 2015 and 2014, excluding amortization of intangible assets and nonâ cash share based compensation: adjusted operating income was $73.2 million compared to $57.2 million for the third quarter of fiscal year 2014. Adjusted income was $62.6 million, or $2.17 per diluted share, compared to $44.7 million, or $1.37 per diluted share, for the third quarter of fiscal year 2014. For the nine months, the company reported sales revenue of $1,067.401 million compared to $1,004.633 million a year ago. Income before income taxes were $101.415 million compared to $92.880 million a year ago. Net income was $90.614 million compared to $75.233 million a year ago. Diluted EPS was $3.12 compared to $2.33 a year ago. EBITDA was $142.031 million compared to $125.662 million a year ago. Adjusted EBITDA was $159.181 million compared to $146.911 million a year ago. Foreign currency exchange rate fluctuations decreased reported net sales revenue by $2.1 million year-over-year. Operating income was $112.8 million, which includes $9.0 million in non-cash asset impairment charges related to certain trademarks in the Company’s Personal Care segment. This is compared to operating income of $100.4 million in the same period last year. On an adjusted basis for the first nine months of fiscal years 2015 and 2014, excluding non-cash asset impairment charges, acquisition-related expenses, amortization of intangible assets and non cash share based compensation in both periods, as applicable: adjusted operating income was $148.3 million compared to $137.9 million for the first nine months of fiscal year 2014. Adjusted income was $121.9 million, or $4.19 per diluted share, compared to $110.2 million, or $3.41 per diluted share, for the first nine months of fiscal year 2014. For fiscal year 2015, the Company has revised its expectation upward to reflect the higher than expected third quarter results. The company now expects net sales revenue excluding Healthy Directions in the range of $1.290 billion to $1.315 billion, and diluted EPS (GAAP) in the range of $3.88 to $3.98, which includes after-tax non-cash asset impairment charges of $0.28 per share. The company continues to expect projected sales and diluted EPS (GAAP) from the Healthy Directions acquisition to be in the range of $100 million to $105 million and $0.12 to $0.16, respectively, for the eight months included in fiscal year 2015 results. The Company now expects consolidated net sales revenue including Healthy Directions in the range of $1.390 to $1.420 billion and diluted EPS (GAAP) in the range of $4.00 to $4.14. The Company now expects adjusted diluted EPS (non-GAAP) excluding Healthy Directions to be in the range of $5.01 to $5.11, which excludes after-tax non-cash asset impairment charges, intangible asset amortization expense, and non-cash share-based compensation expense. The Company continues to expect adjusted diluted EPS (non-GAAP) for Healthy Directions to be in the range of $0.32 to $0.36, which excludes after-tax acquisition-related expenses, intangible asset amortization expense, and non-cash share-based compensation expense. The company now expects consolidated adjusted diluted EPS (non-GAAP) including Healthy Directions to be in the range of $5.33 to $5.47.

Helen of Troy Seeks Acquisitions

Helen of Troy Limited (NasdaqGS:HELE) is seeking acquisitions. Julien Mininberg, Cheif Executive Officer of Helen of Troy said "Our business generates strong cash flow, allowing us to continue to leverage the organic growth potential of our existing businesses, while actively pursuing acquisition opportunities that are the right fit for us and would be accretive to bottom line."

Helen of Troy Limited to Report Q3, 2015 Results on Jan 08, 2015

Helen of Troy Limited announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Jan 08, 2015

Helen of Troy Limited, Q3 2015 Earnings Call, Jan 08, 2015

Helen of Troy Limited, Q3 2015 Earnings Call, Jan 08, 2015

Gerald (Jerry) Rubin Files Suit Against Helen of Troy Limited

Gerald (Jerry) Rubin, the founder and former CEO of Helen of Troy Limited filed suit against the company and certain members of its Board of Directors to right the alleged wrongs committed by a troupe of highly paid outside consultants and the Director Defendants, who were too afraid, and too self-interested, to stop them. In his lawsuit, Mr. Rubin alleges that Defendants misrepresented and breached the terms of his Employment Agreements with Helen of Troy. In particular, Mr. Rubin contends that the Director Defendants did so in an effort to save their own jobs when under fire by outside proxy advisory firm Institutional Shareholder Services. Specifically, Mr. Rubin alleges that, contrary to the best interests of the company and its shareholders - and with respect to the Director Defendants, to preserve their own interests - the Defendants engaged in a calculated campaign of unfair dealings that culminated in the groundless firing of Mr. Rubin earlier this year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HELE:US $80.32 USD +0.26

HELE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
De' Longhi €20.03 EUR -0.38
Elizabeth Arden Inc $15.74 USD -0.03
Prestige Brands Holdings Inc $42.43 USD +1.06
Revlon Inc $39.67 USD -0.07
USANA Health Sciences Inc $111.38 USD +4.02
View Industry Companies
 

Industry Analysis

HELE

Industry Average

Valuation HELE Industry Range
Price/Earnings 23.7x
Price/Sales 1.7x
Price/Book 2.7x
Price/Cash Flow 22.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HELEN OF TROY LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.